B of A Securities Initiates Coverage On Madrigal Pharmaceuticals With Underperform Rating, Announces Price Target of $150
B of A Securities Initiates Coverage On Madrigal Pharmaceuticals With Underperform Rating, Announces Price Target of $150
B of A Securities以表現不佳的評級啓動對Madrigal製藥的報道，宣佈目標股價爲150美元
B of A Securities analyst Alexandria Hammond initiates coverage on Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Underperform rating and announces Price Target of $150.
B of A Securities分析師亞歷山大·哈蒙德以表現不佳的評級啓動了對Madrigal Pharmicals（納斯達克股票代碼：MDGL）的報道，並宣佈目標股價爲150美元。